2017
DOI: 10.1007/s10517-017-3847-2
|View full text |Cite|
|
Sign up to set email alerts
|

Tripeptides Restore the Number of Neuronal Spines under Conditions of In Vitro Modeled Alzheimer’s Disease

Abstract: In primary culture of mouse hippocampal neurons, peptide EDR (200 ng/ml) under conditions of amyloid synaptotoxicity (a model of Alzheimer's disease) increased the number of mushroom spines by 71% and returned this parameter to the normal level. Under the same conditions, tripeptide KED (200 ng/ml) increased the number of mushroom spines in hippocampal neurons by 20%. Tripeptide EDR can be recommended for further experimental study as a candidate neuroprotective agent for prevention and treatment of Alzheimer'… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…However, few of them focused on the effects on target tissues, and the amount of active ingredients reached target tissues simultaneously. For instance, in the research of neuroprotective peptides, the effects of combination treatment on nerve cells have been extensively studied, but the distribution of peptides in the brain is always neglected. , In this study, we found that TP was able to not only enhance the protective effect of DWMH-derived peptides on oxidatively damaged nerve cells but also promote the accumulation of peptides in brain tissue. The enhancement of TP on memory impairment reversal effects of DWMH in vivo is attributed to the above two aspects.…”
Section: Discussionmentioning
confidence: 67%
“…However, few of them focused on the effects on target tissues, and the amount of active ingredients reached target tissues simultaneously. For instance, in the research of neuroprotective peptides, the effects of combination treatment on nerve cells have been extensively studied, but the distribution of peptides in the brain is always neglected. , In this study, we found that TP was able to not only enhance the protective effect of DWMH-derived peptides on oxidatively damaged nerve cells but also promote the accumulation of peptides in brain tissue. The enhancement of TP on memory impairment reversal effects of DWMH in vivo is attributed to the above two aspects.…”
Section: Discussionmentioning
confidence: 67%
“…Increased the amount of mushroom spines in hippocampal neurons in Alzheimer disease culture mouse model by 20%. 25 5. Stimulated serotonin expression in neuronal cell culture.…”
Section: Mtt Assaymentioning
confidence: 99%
“…It is significant that the KED vasoprotective peptide [60], which has a neuroprotective effect in models of Alzheimer's disease in mice in vitro and in vivo [61,62], regulated the mRNA involved in expression of the cell senescence and apoptosis genes (p16, p21), of neurogenesis (NES, GAP43), and of other genes involved in the pathogenesis of Alzheimer's disease (SUMO1, APOE, IGF1) [22]. It should be noted that as such short peptides can regulate the expression of genes responsible for functions of the cell populations of the brain, this indicates promising prospects for using short peptides for neuroprotection.…”
Section: Peptide Regulation Of the Functional Activity Of Cellsmentioning
confidence: 99%